Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
233 studies found for:    Open Studies | "Urinary Bladder Neoplasms"
Show Display Options
Rank Status Study
1 Recruiting Irreversible Electroporation(IRE) For Unresectable Urinary Bladder Neoplasms
Condition: Urinary Bladder Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
2 Recruiting Confocal Microscopy Dual Band in the Management of Bladder Cancer
Condition: Urinary Bladder Neoplasm
Intervention: Device: Cellvizio dual band
3 Recruiting Molecular Biosensors for Detection of Bladder Cancer
Condition: Urinary Bladder Neoplasms
Intervention:
4 Recruiting uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer
Condition: Urinary Bladder Neoplasms
Interventions: Drug: Injection of 68Ga-NOTA-AE105;   Drug: Injection of 18F-FDG;   Device: Positron Emission Tomography and CT;   Device: Positron Emission Tomography and MRI
5 Not yet recruiting TURBt With Adjuvant Cryoablation to Treat Bladder Cancer
Condition: Urinary Bladder Neoplasms
Intervention: Procedure: Cryoablation
6 Recruiting Laser En Bloc Resection Of Bladder Tumor (HoLERBT) VS. Conventional Transurethral Resection Of Bladder Tumors (cTURBT)
Condition: Bladder Cancer
Interventions: Device: HoLERBT;   Device: cTURBT
7 Recruiting Biomarker Identification for Bladder Cancer Patients
Condition: Bladder Cancer
Intervention: Procedure: Sample Collection
8 Recruiting PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder Tumors
Condition: Bladder Cancer
Interventions: Device: Monopolar electrocautery loop in Transurethral resection of bladder tumors;   Device: PK Button Vaporization Electrode in transurethral resection of bladder tumors
9 Recruiting Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: Pembrolizumab;   Drug: Cisplatin;   Radiation: Radiotherapy
10 Recruiting Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Drug: mitomycin C
11 Recruiting Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors
Condition: Bladder Cancer
Intervention: Drug: Tamoxifen Citrate
12 Not yet recruiting Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: Celecoxib;   Drug: Gemcitabine;   Drug: Cisplatin
13 Recruiting Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Bladder Cancer
Condition: Urinary Bladder Neoplasms
Interventions: Drug: Gemcitabine;   Drug: Paclitaxel;   Drug: Cisplatin
14 Recruiting Enzalutamide for Bladder Cancer Chemoprevention
Condition: Bladder Cancer
Intervention: Drug: Enzalutamide
15 Recruiting Exploratory Investigation of Advanced PET/MRI Metrics for Bladder Cancer Characterization
Condition: Bladder Cancer
Intervention: Device: PET/MRI
16 Recruiting VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer
Condition: Bladder Cancer
Intervention: Drug: VPM1002BC
17 Not yet recruiting Investigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: Mitomycin C;   Procedure: Surgical Management
18 Recruiting Metformin and Simvastatin Use in Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: Metformin;   Drug: Simvastatin
19 Recruiting The Bladder Instillation Comparison Study
Condition: Urinary Bladder Neoplasms
Interventions: Drug: Mitomycin C;   Drug: Gemcitabine
20 Recruiting A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting
Condition: Bladder Cancer
Interventions: Drug: Hexaminolevulinate hydrochloride;   Device: KARL STORZ D-Light C PDD Flexible Videoscope System

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.